Session Details
[2-YIA-DC]YIA-DC
Tue. Mar 17, 2026 2:40 PM - 3:40 PM JST
Tue. Mar 17, 2026 5:40 AM - 6:40 AM UTC
Tue. Mar 17, 2026 5:40 AM - 6:40 AM UTC
Room 8(B204)
Chair:Takeshi Nabe(Setsunan University, Faculty of Pharmaceutical Sciences), Takahiro Horinouchi(International University of Health and Welfare)
[2-YIA-DC-15]Celecoxib derivative OSU-03012 ameliorated pulmonary fibrosis through modulation of ECM remodeling
*Kohei Hashimoto1,2, Masaki Arioka1, Masahiro Tahara2, Kazuhiro Yatera2, Fumi Takahashi1 (1. Department of Pharmacology, School of Medicine, University of Occupational and Environmental Health, Japan, 2. Department of Respiratory Medicine, School of Medicine, University of Occupational and Environmental Health, Japan)
[2-YIA-DC-16]Identification of the Gingipain-PAR-2-CCL20-γδT cell axis in periodontal disease-associated COPD
*Keisuke Kawano1, Noriki Takahashi1, Toru Kariu2, Tomoki Kishimoto1, Mai Uemura1, Kota Nakajima1, Yukio Fujiwara3, Mary Ann Suico1, Hirofumi Kai1, Tsuyoshi Shuto1 (1. Department of Molecular Medicine, Graduate School of Pharmaceutical Sciences, Kumamoto University, 2. Faculty of Food Science & Nutrition, Beppu University, 3. Department of Cell Pathology, Graduate School of Medical Science, Kumamoto University)
[2-YIA-DC-17]Involvement of RAMP1 signaling in pulmonary emphysema
*Takahiro Honda1,2, Yoshiya Ito3,2, Atsushi Yamashita4, Seishiro Akinaga2, Saori Hokama1,2, Takuya Yamazaki2, Mariko Kamata3,2, Kanako Hosono3,2, Kazutake Tsujikawa5, Hideki Amano3,2 (1. Kitasato University, Graduate School of Medical Sciences, Department of Anesthesiology, 2. Kitasato University Graduate School of Medical Sciences, Department of Molecular Pharmacology, 3. Kitasato University, School of Medicine, Department of Pharmacology, 4. Kitasato University, School of Medicine, Department of Anesthesiology, 5. Osaka University, Graduate School of Pharmaceutical Sciences, Laboratory of Molecular and Cellular Physiology)
[2-YIA-DC-18]Chinese quince extract suppresses MUC5AC production via accelerating mRNA degradation.
*Miyuki Shimomura1, Shin-ichi Muroi1, Tomonori Ando2, Nami Hikida2, Chihiro Kobayashi3, Yoichiro Isohama1 (1. Lab. Appl. Pharmacol, Fac. Pharmac. Sci., Tokyo Univ. Sci., 2. Research and Development Center, Frontier R&D Section, Lotte Co., Ltd., 3. Research and Development Center, Candy R&D Section, Lotte Co.,Ltd.)